Unravelling the Role of HIF-1α in Sepsis
- Sepsis
- 02/04/2024
A recent review explores the crucial role of hypoxia-inducible factor-1α (HIF-1α) in the development and progression of sepsis. Hypoxia-induc
READ MOREA recent review explores the crucial role of hypoxia-inducible factor-1α (HIF-1α) in the development and progression of sepsis. Hypoxia-induc
READ MORESepsis remains a major cause of mortality, accounting for nearly 20% of global deaths. Microcirculatory dysfunction, marked by irregular blood
READ MOREFindings presented at #ISICEM24 show that novel host transcriptomic signatures specific for bacterial and viral infection in children evaluated for...
READ MOREAn overview of landiolol, a potent and cardioselective beta-blocker offering a promising addition to the armamentarium for managing acute cardiac conditions for rapid and effective rate control with minimal adverse effects. Cardiac emergencies present complex challenges in emergency medical settings, requiring prompt and effective management...
READ MORESepsis is characterised by dysregulated immune responses. Traditional approaches to treating sepsis by targeting proinflammatory and immunosup
READ MOREEarly recognition and initiation of antibiotics are crucial in managing sepsis. Various warning scores, including qSOFA (quick Sequential Orga
READ MOREIn a subgroup analysis of the Activated Protein C and Corticosteroids for Human Septic Shock (APROCCHSS) trial, researchers aimed to explore...
READ MORENearly 1.7 million adults in the United States contract sepsis annually, with approximately 350,000 succumbing to the condition. In
READ MORESepsis, characterised by severe organ dysfunction, is a major cause of hospitalisation and mortality globally. The WHO recognises sepsis as a significa
READ MOREKey Updates, Including ePV, for Managing Sepsis and Septic Shock
READ MORE